Without Patented Drugs, There's No Generics Industry: Mylan CEO

Novartis’ and Bayer’s patent battles in India reflect the increasing legal nature of the globalising pharma industry, Mylan Inc CEO Heather Bresch tells Forbes India

(A link to this page will be included in your message)


Email

Your Name
Required
Email Address
Required
 Send me a copy
Recipient's Email Address
Required
Separate multiple email addresses with commas (max 20)
Your Message
(1000 characters max)
"The details you provide on this page will not be used to send unsolicited e-mail, and will not be sold to a 3rd party."